ARKK vs. PBE ETF Comparison
Comparison of ARK Innovation ETF (ARKK) to PowerShares Dynamic Biotech & Genome (PBE)
ARKK
ARK Innovation ETF
ARKK Description
The investment seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 65% of its assets) in domestic and foreign equity securities of companies that are relevant to the fund's investment theme of disruptive innovation. Its investments in foreign equity securities will be in both developed and emerging markets. The fund currently intends to use only American Depositary Receipts ("ADRs") when purchasing foreign securities. It is non-diversified.
Grade (RS Rating)
Last Trade
$43.01
Average Daily Volume
11,208,926
35
PBE
PowerShares Dynamic Biotech & Genome
PBE Description
The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.Grade (RS Rating)
Last Trade
$64.09
Average Daily Volume
12,084
30
Performance
| Period | ARKK | PBE |
|---|---|---|
| 30 Days | -3.13% | 0.69% |
| 60 Days | -13.79% | -1.75% |
| 90 Days | -16.99% | -5.91% |
| 12 Months | 4.12% | 3.95% |
1 Overlapping Holdings
| Symbol | Grade | Weight in ARKK | Weight in PBE | Overlap | |
|---|---|---|---|---|---|
| VCYT | D | 1.31% | 2.27% | 1.31% |
ARKK Overweight 34 Positions Relative to PBE
| Symbol | Grade | Weight | |
|---|---|---|---|
| TSLA | D | 11.63% | |
| COIN | D | 9.47% | |
| ROKU | F | 8.32% | |
| SQ | D | 5.84% | |
| PATH | F | 5.5% | |
| RBLX | F | 5.14% | |
| HOOD | D | 5.07% | |
| CRSP | F | 4.87% | |
| ZM | D | 3.62% | |
| PLTR | D | 3.13% | |
| SHOP | F | 2.94% | |
| NTLA | F | 2.65% | |
| U | F | 2.48% | |
| TWST | B | 2.17% | |
| TTD | B | 2.17% | |
| PDFS | C | 2.14% | |
| DKNG | D | 2.13% | |
| META | D | 2.1% | |
| RXRX | F | 2.03% | |
| BEAM | F | 1.99% | |
| TER | A | 1.89% | |
| PINS | B | 1.86% | |
| TXG | F | 1.83% | |
| MRNA | C | 1.6% | |
| TDOC | F | 1.3% | |
| DNA | F | 1.13% | |
| SOFI | F | 1.01% | |
| ACHR | F | 0.78% | |
| PACB | F | 0.55% | |
| NTRA | B | 0.37% | |
| CERS | F | 0.31% | |
| PRME | F | 0.26% | |
| EXAS | F | 0.22% | |
| VERV | F | 0.16% |
ARKK Underweight 29 Positions Relative to PBE
| Symbol | Grade | Weight | |
|---|---|---|---|
| TECH | B | -5.72% | |
| AMGN | B | -5.41% | |
| VRTX | C | -5.37% | |
| NBIX | C | -5.3% | |
| REGN | C | -5.18% | |
| BIIB | C | -4.98% | |
| GILD | F | -4.6% | |
| BMRN | F | -4.29% | |
| PTCT | C | -3.9% | |
| MNKD | D | -3.66% | |
| UTHR | B | -3.53% | |
| TGTX | C | -3.5% | |
| HALO | B | -3.33% | |
| CPRX | C | -3.15% | |
| BPMC | B | -3.06% | |
| COLL | D | -2.88% | |
| QGEN | B | -2.75% | |
| EXEL | F | -2.7% | |
| MYGN | A | -2.7% | |
| VCEL | B | -2.65% | |
| DVAX | F | -2.64% | |
| CLDX | D | -2.58% | |
| ITCI | C | -2.46% | |
| IONS | F | -2.34% | |
| XENE | D | -2.17% | |
| RGEN | D | -2.17% | |
| FOLD | F | -1.89% | |
| ACAD | F | -1.71% | |
| EYPT | F | -1.1% |
ARKK: Top Represented Industries & Keywords
PBE: Top Represented Industries & Keywords
Compare ETFs
